Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 32 | +1 |
| Shares | 9.82M | 97.0K | 9.95M | +223.8K (+2.3%) |
| Value | $14.6M | $145.0K | $18.8M | +$4.31M (+29.8%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 41,874 | $79.1K | 0.00% |
| Charles Schwab Investment Management Inc | 22,638 | $42.8K | 0.00% |
| Jane Street Group, LLC | 16,982 | $32.1K | 0.00% |
| Millennium Management LLC | 11,760 | $22.0K | 0.00% |
| Simplex Trading, LLC | 447 | $0 | 0.00% |
Sold out (4)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Virtu Financial LLC | 45,279 | $67.0K |
| Coastal Bridge Advisors, LLC | 10,000 | $14.9K |
| Bank of America Corp | 46 | $68 |
| Morgan Stanley | 7 | $10 |
Not filed for Q1 2023 yet (1)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 97,000 | $145.0K |